top
Search terms
Results 1 - 10 of 40 - ordered by :
Pages: 1 2 3 4
Ehjournal

Abstract Aims Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, ...

European Heart Journal, FASTTRACK ESC Clinical Registry, A. John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Silvia Kuhls, Martin van Eickels, Alexander G.G. Turpie

Date : 07/04/2016 Item size : 258982 bytes
Epeuropace

Preamble Guidelines summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual ...

Europace, ESC GUIDELINES, Authors/Task Force Members, A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina, Irene Savelieva, Dan Atar, Stefan H. Hohnloser, Gerhard Hindricks, Paulus Kirchhof, ESC ...

Date : 01/10/2012 Item size : 1008256 bytes
Epeuropace

Abstract Aims The aim of this study was to describe the characteristics of patients with atrial fibrillation (AF) enrolled in the Central Registry of the German Competence NETwork on Atrial ...

Europace, Michael Nabauer, Andrea Gerth, Tobias Limbourg, Steffen Schneider, Michael Oeff, Paulus Kirchhof, Andreas Goette, Thorsten Lewalter, Ursula Ravens, Thomas Meinertz, Günter Breithardt, ...

Date : 01/04/2009 Item size : 335186 bytes
Ejhf

[1] AF is associated with a five-fold increase in the risk of stroke, a three-fold increase in the risk of heart failure, and a doubling in the risk of dementia and death. The EuroHeart Survey ...

European Journal of Heart Failure, Mulder, Bart A., Schnabel, Renate B., Rienstra, Michiel

Date : 01/04/2013 Item size : 76898 bytes
Eurointervention

Medical Clinic I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany Aims: The aim of this study was to determine the opinion of the scientific community regarding percutaneous left ...

Date : 16/05/2016 Item size : 34612 bytes
Epeuropace

Phase I, baseline cohort before the introduction of non-VKA oral anticoagulants (NOACs); Phase II, just after the introduction of the first NOAC dabigatran, with 2-year follow-up in ...

Europace, CLINICAL RESEARCH, Menno V. Huisman, Chang Sheng Ma, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Kenneth J. Rothman, Christine Teutsch, Nils Schoof, Eva Kleine, Dorothee ...

Date : 01/09/2016 Item size : 261631 bytes
Epeuropace

Abstract Clinical practice should follow guidelines and recommendations mainly based on the results of controlled trials, which are often conducted in selected populations and special conditions, ...

Europace, EP WIRE, Maria Grazia Bongiorni, Jian Chen, Nikolaos Dagres, Heidi Estner, Antonio Hernandez-Madrid, Meleze Hocini, Torben Bjerregaard Larsen, Laurent Pison, Tatjana Potpara, Alessandro ...

Date : 01/11/2015 Item size : 285508 bytes
Epeuropace

Abstract The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) ...

Europace, EP WIRE, Gregory Y.H. Lip, Nikolaos Dagres, Alessandro Proclemer, Jesper Hastrup Svendsen, Laurent Pison, Carina Blomstrom-Lundqvist, conducted by the Scientific Initiative ...

Date : 01/01/2013 Item size : 149356 bytes
Epeuropace

For this reason, we believe that proper communication between pacemaker clinics and family physicians or other cardiologists is crucial, as it has been concluded by our colleagues and our own data.1 ...

Europace, Letter to the Editor, Sandra Cabrera, Jordi Mercé, Ramon de Castro, Carlos Aguirre, Ana Carmona, Mar Pinedo, Marta Salmerón, Alfredo Bardají

Date : 01/09/2012 Item size : 112116 bytes
AnatolianJournal

Hatice Selçuk1, M. Timur Selçuk2, Orhan Maden2 1Türkiye Yüksek Ýhtisas Hastanesi, Kardiyoloji Kliniði Ankara, Türkiye 2Türkiye Yüksek Ýhtisas Hastanesi, Kardiyoloji ...

Date : 12/01/2017 Item size : 34551 bytes